Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Article

Anadolu Psikiyatri Derg. 2020; 21(5): 461-467


Efficacy of mirtazapine in neuropathic pain model

Şeyda Figül Gokçe, Burhanettin Çigdem.

Abstract
Objective: Neuropathic pain, which is chronic pain, can affect the quality of life individuals. It can cause psychiatric problems such as depression and anxiety. Mirtazapine is an atypical antidepressant which has both noradrenergic and specific serotonergic receptor antagonism and shown to have anxiolytic, anti-emetic and appetite stimulating effects along with its antidepressant effect. It is generally tolerated better and has a different way of action when compared with other antidepressants used to treat neuropathic pain. Thus, we aimed to investigate its potential preventive effect in neuropathic pain in nerve ligated rat model. Methods: Forty rats were divided into five groups including the sham, the sciatic nerve ligation group and the third, fourth and fifth sciatic nerve ligation+mirtazepine groups which were treated with 5 mg, 10 mg and 15 mg/day mirtazapine, respectively. The tail flick and hot plate tests were performed on all the five groups, and the latency times were measured. Morphine was used as a positive control agent. Results: Administration of mirtazapine, restored both tail flick and hot plate latencies in a dose-dependent manner, meaning that mirtazapine is effective in treating neuropathic pain in this animal model. Mirta-zapine also restored the antinociceptive response to morphine significantly. Discussion: Mirtazapine appears to be good candidate for both neuropathic pain treatment and accompanying psychiatric condition such as depression and anxiety with its dual effect on neurotransmitters.

Key words: Mirtazapine,Neuropathic Pain



Article Language: Turkish English



Similar Articles

Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice.
Jansen C, Baker JD, Kodaira E, Ang L, Bacani AJ, Aldan JT, Shimoda LMN, Salameh M, Small-Howard AL, Stokes AJ, Turner H, Adra CN
Journal of ethnopharmacology. 2021; 267(): 113477

Effect of Lavender Aromatherapy On Arteriovenous Fistula Puncture Pain and the Level of State and Trait Anxiety in Hemodialysis Patients: A Randomized Controlled Trial.
Şahin S, Tokgöz B, Demir G
Pain management nursing : official journal of the American Society of Pain Management Nurses. 2021; ():

Understanding the immune drivers of food-induced abdominal pain.
Ray K
Nature reviews. Gastroenterology & hepatology. 2021; ():

Efficacy, safety, and tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
Hashemi M, Zali A, Golmakani E, Delshad MH, Shadnoush M, Akbari ME
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2021; ():

The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial.
Wang SJ, Wang YH, Huang LC
Medicine. 2021; 100(5): e24252

A rare case of right shoulder pain.
Bansari A, Radhakrishnan NS, Kattan JN
BMJ case reports. 2021; 14(2):

Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.
Hernanz de Lucas R, Nuñez Fernández M, Gómez-Caamaño A, Morera López R, Fortes de la Torre I, de la Torre Tomás A, Muñoz-Garzón V, López Bermudo C, Mañas Rueda A
Future oncology (London, England). 2021; 17(8): 943-954

Cross-sectional study of psychosocial and pain-related variables among patients with chronic pain during a time of social distancing imposed by the coronavirus disease 2019 pandemic.
Hruschak V, Flowers KM, Azizoddin DR, Jamison RN, Edwards RR, Schreiber KL
Pain. 2021; 162(2): 619-629


Full-text options






Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.